| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study
|
Zhang, Yumeng
|
|
|
22 |
8 |
p. e770-e776
|
article
|
| 2 |
Baseline Total Metabolic Tumor Volume is Prognostic for Refractoriness to Immunochemotherapy in DLBCL: Results From GOYA
|
Ruiz, Irene Canales
|
|
|
22 |
8 |
p. e804-e814
|
article
|
| 3 |
Clinico-hematological and Outcome Profile of Pediatric B-other-ALL and BCR::ABL1-like pre-B-ALL: An Integrated Genomic Study From North India
|
Peyam, Srinivasan
|
|
|
22 |
8 |
p. e667-e679
|
article
|
| 4 |
COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
|
Ito, Yusuke
|
|
|
22 |
8 |
p. e691-e707
|
article
|
| 5 |
Current Status of CPX-351 Therapy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
|
Alotaibi, Shaykhah
|
|
|
22 |
8 |
p. 575-580
|
article
|
| 6 |
‘Fast but not so Furious’: Short observation time after subcutaneous Daratumumab administration is both a safe and cost-effective strategy
|
Davis, James A.
|
|
|
22 |
8 |
p. e680-e684
|
article
|
| 7 |
Incidence and Prognostic Significance of High-Risk Cytogenetically Abnormalities in Multiple Myeloma Patients in Colombia
|
Combariza, Juan Felipe
|
|
|
22 |
8 |
p. 601-607
|
article
|
| 8 |
Indolent Lymphoproliferative T-Cell Disorders Associated With Gastrointestional Disease: Diagnostic Challenges and Outcomes
|
Masciopinto, Pierluigi
|
|
|
22 |
8 |
p. e745-e750
|
article
|
| 9 |
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup Analysis
|
Sunami, Kazutaka
|
|
|
22 |
8 |
p. e751-e761
|
article
|
| 10 |
Lack of Renal Recovery Predicts Poor Survival in Patients of Multiple Myeloma With Renal Impairment
|
Sharma, Rintu
|
|
|
22 |
8 |
p. 626-634
|
article
|
| 11 |
Leukemic High Grade B Cell Lymphoma is Associated With MYC Translocation, Double Hit/Triple Hit Status, Transformation, and CNS Disease Risk: The Mayo Clinic Experience
|
Kuhlman, Justin J.
|
|
|
22 |
8 |
p. e815-e825
|
article
|
| 12 |
Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma
|
Hamadani, Mehdi
|
|
|
22 |
8 |
p. e738-e744
|
article
|
| 13 |
Māori and Pacific Peoples With Multiple Myeloma in New Zealand are Younger and Have Inferior Survival Compared to Other Ethnicities: A Study From the Australian and New Zealand Myeloma and Related Diseases Registry (MRDR)
|
Moore, Elizabeth M
|
|
|
22 |
8 |
p. e762-e769
|
article
|
| 14 |
Outcomes of Tisagenlecleucel in Lymphoma Patients With Predominant Management in an Ambulatory Setting
|
Nasta, Sunita D.
|
|
|
22 |
8 |
p. e730-e737
|
article
|
| 15 |
Patient characteristics, treatment patterns, and outcomes among black and white patients with multiple myeloma initiating daratumumab: A real-world chart review study
|
Atrash, Shebli
|
|
|
22 |
8 |
p. e708-e715
|
article
|
| 16 |
Pembrolizumab for the Treatment of Relapsed and Refractory Classical Hodgkin Lymphoma After Autologous Transplant and in Transplant-Naïve Patients
|
Halahleh, Khalid
|
|
|
22 |
8 |
p. 589-595
|
article
|
| 17 |
Predicting the Risks of Aggressive-Intent Chemotherapy Toxicity in Older Patients With Lymphoma: A Prospective Observational Pilot Study
|
Dhir, Vinita
|
|
|
22 |
8 |
p. e792-e803
|
article
|
| 18 |
Presentation and Impact of Double and Triple hit Cytogenetics in Patients With Multiple Myeloma in the Real World
|
Singh, Charanpreet
|
|
|
22 |
8 |
p. e685-e690
|
article
|
| 19 |
Pretransplant Consolidation Therapies Improve the Outcome of Myeloablative Allogeneic Transplantation in Adults with Ph-negative Acute Lymphoblastic Leukemia
|
Ozdemir, Zehra Narli
|
|
|
22 |
8 |
p. 596-600
|
article
|
| 20 |
Prolonged Lenalidomide Induction Does Not Significantly Impair Stem Cell Collection in Multiple Myeloma Patients Mobilized With Cyclophosphamide or Plerixafor: A Report From The Covid Era
|
Rybinski, Brad
|
|
|
22 |
8 |
p. e716-e729
|
article
|
| 21 |
Real-World Evidence of Daratumumab Monotherapy in Relapsed/Refractory Multiple Myeloma Patients and Efficacy on Soft-Tissue Plasmacytomas
|
Moreno, David F.
|
|
|
22 |
8 |
p. 635-642
|
article
|
| 22 |
Real World Long-term Follow-up Experience with Yttrium-90 ibritumomab tiuxetan in Previously Untreated Patients with Low-Grade Follicular Lymphoma and Marginal Zone Lymphoma
|
Alhaj Moustafa, Muhamad
|
|
|
22 |
8 |
p. 618-625
|
article
|
| 23 |
Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study
|
Correia, Emily
|
|
|
22 |
8 |
p. 581-588
|
article
|
| 24 |
Results of a Prospective Non-Interventional Post-Authorization Safety Study of Idelalisib in Germany
|
Hoechstetter, Manuela A.
|
|
|
22 |
8 |
p. e777-e787
|
article
|
| 25 |
SOHO State of the Art Updates and Next Questions: Managing Relapsed Mantle Cell Lymphoma
|
Romancik, Jason T.
|
|
|
22 |
8 |
p. 557-565
|
article
|
| 26 |
SOHO State of the Art Updates and Next Questions: Novel Transplant and Post-Transplant Options in Acute Lymphoblastic Leukemia
|
Logan, Aaron C.
|
|
|
22 |
8 |
p. 569-574
|
article
|
| 27 |
SOHO State of the Art Updates and Next Questions: Targeted therapies and emerging novel treatment approaches for Waldenström Macroglobulinemia
|
Sermer, David
|
|
|
22 |
8 |
p. 547-556
|
article
|
| 28 |
Standard 30-minute Monitoring Time and Less Intensive Pre-medications is Safe in Patients Treated With Subcutaneous Daratumumab for Multiple Myeloma and Light Chain Amyloidosis
|
Hughes, David M.
|
|
|
22 |
8 |
p. 566-568
|
article
|
| 29 |
Survival and Outcomes of Newly Diagnosed Multiple Myeloma Patients Stratified by Transplant Status 2007-2018: Retrospective Analysis from the Canadian Myeloma Research Group Database
|
Mian, Hira
|
|
|
22 |
8 |
p. 608-617
|
article
|
| 30 |
Waldenstrom macroglobulinemia and simultaneous intravascular large B-cell lymphoma: Rare transformation or unhappy coincidence?
|
Kline, Kathryn A.F.
|
|
|
22 |
8 |
p. e788-e791
|
article
|
Journal description